Effect of systemic granulocyte-colony stimulating factor versus placebo on implantation in infertile wome
Phase 3
- Conditions
- Infertility.Female infertility
- Registration Number
- IRCT201511269014N85
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 36
Inclusion Criteria
(a) being infertile; (b) age of 20 to 40 years.
Exclusion criteria: (a) contraindication of pregnancy; (b) secondary infertility due to background disease; (c) infertility because of her spouse; (d) weak response to gonadotropin.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the formation of gestational sac. Timepoint: 3 weeks after intervention. Method of measurement: By transvaginal ultrasound.
- Secondary Outcome Measures
Name Time Method Assessing beta human chorionic gonadotropin. Timepoint: 10 days after intervention. Method of measurement: By laboratory test.